DTC広告
参照資料

↑  Mogull, Scott A.; Balzhiser, Deborah (September 2015). “Pharmaceutical Companies Are Writing the Script for Health Consumerism”. Commun. Des. Q. Rev. 3 (4):  35–49. doi:10.1145/2826972.2826976.
1 2  “Direct-to-consumer advertising of prescription medication in New Zealand”.   New Zealand Medical Journal. 2019年5月15日閲覧。
↑  Lazarus. “Direct-to-consumer drug ads: A bad idea that's about to get worse”. Los Angeles Times. 2019年5月15日閲覧。
1 2 3 4  Mogull, Scott A. (2008). “Chronology of Direct-to-Consumer Advertising Regulation in the United States”. AMWA Journal 23:  3. https://www.academia.edu/278465.
1 2 3 4 5 6  “A history of drug advertising: the evolving roles of consumers and consumer protection”. The Milbank Quarterly 84 (4):  659–99. (2006). doi:10.1111/j.1468-0009.2006.00464.x. PMC 2690298. PMID 17096638. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690298/.
1 2  “A Guide To Television Drug Advertising”. American Council on Science and Health (2018年5月30日). 2019年5月11日閲覧。
1 2 3 4  “Basics of Drug Ads”. Center for Drug Evaluation and Research (FDA). (2019-02-08). https://www.fda.gov/drugs/prescription-drug-advertising/basics-drug-ads.
1 2 3 4 5  Fayerman. “Health Canada fails to properly regulate drug ads: 10-year study (updated)”. Vancouver Sun. 2019年5月11日閲覧。
1 2  Ono. “Advertising Fine Print in Drug Ads Sparks A Debate Among Marketers”. The Wall Street Journal. 2019年5月12日閲覧。
1 2  Russell. “Do drug ads help patients or lead to expensive treatments?”. Chicago Tribune. 2019年5月12日閲覧。
1 2 3 4  “Drug makers said to skirt Canadian restrictions on ads”. The Globe and Mail. https://www.theglobeandmail.com/report-on-business/drug-makers-said-to-skirt-canadian-restrictions-on-ads/article22618551/ 2019年5月11日閲覧。
↑  Rosenthal, Elisabeth (2016年2月27日). “Ask Your Doctor if This Ad Is Right for You”. The New York Times. ISSN 0362-4331. https://www.nytimes.com/2016/02/28/sunday-review/ask-your-doctor-if-this-ad-is-right-for-you.html 2019年5月11日閲覧。
↑  Meiselman. “The sneaky way pharmaceutical companies use celebs to market their drugs”. The Outline. 2019年5月12日閲覧。
↑  強みを活かす協力関係の先に究極のゴール 情報過多社会における製薬企業の患者啓発の重要性 くすりの適正使用競技会（RAD-AR） (PDF)
↑  “第2回 DTCの語源”.  株式会社アーベーツェー. 2019年12月17日閲覧。
↑  “DTC広告”.  製薬・医薬業界の転職支援 アンサーズ. 2019年12月17日閲覧。
↑  「「第3回 コード・プライアンス管理責任者/実務担当者会」を開催」『ニューズレター』第179号、日本製薬工業協会、2017年5月、2019年12月17日閲覧。
↑  井上良一「21世紀の医薬品マーケティング」『The Japanese Journal of Antibiotics』第58巻第2号、日本感染症医薬品協会、2005年4月、211(107)、2019年12月17日閲覧。
↑  “RESOLUÇÃO-RDC Nº 96, DE 17 DE DEZEMBRO DE 2008”. October 17, 2016時点のオリジナルよりアーカイブ。August 13, 2017閲覧。
↑  “Advertising Regulation for Medication in Brazil”. The Brazil Business. http://thebrazilbusiness.com/article/advertising-regulation-for-medication-in-brazil February 21, 2018閲覧。
↑  Mintzes, Barbara (February 2009). “Should Canada allow direct-to-consumer advertising of prescription drugs?”. Canadian Family Physician 55 (2):  131–133. ISSN 0008-350X. PMC 2642505. PMID 19221067. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2642505/.
↑  “Prescription drug ad law notable for 'lack of teeth'”. CBC News (December 10, 2014). May 11, 2019閲覧。
↑  Cozens, Claire (2002年10月23日). “Europe rejects drug advertising”. The Guardian. ISSN 0261-3077. https://www.theguardian.com/media/2002/oct/23/advertising.marketingandpr 2019年5月13日閲覧。
↑  Praet, Carolus; Cameron, Glen T.; Chien, Monica. “Pharmaceutical Advertising in Korea, Japan, Hong Kong, Australia, and the US: Current Conditions and Future Directions”. Health Communication Research, 3(1), Pp. 1-63.. https://www.academia.edu/3848441.
↑  “Kiwi doctors lobby for crackdown on drug ads”. Stuff. 2019年5月11日閲覧。
↑  “Doctors in New Zealand—the only non-U.S. country that allows DTC advertising—call for bans”. FiercePharma. 2019年5月11日閲覧。
↑  “A basic guide to prescription-only medicines”.   Advertising Standards Authority. 2019年5月15日閲覧。
↑  Schofield (2017年7月10日). “Pharma marketing: UK vs US”. Pharmafield. 2019年5月13日閲覧。
↑  “Drug companies say no to consumer advertising in UK”. www.campaignlive.co.uk. 2019年5月13日閲覧。
1 2  Donohue, Julie (December 2006). “A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection”. The Milbank Quarterly 84 (4):  659–699. doi:10.1111/j.1468-0009.2006.00464.x. ISSN 0887-378X. PMC 2690298. PMID 17096638. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690298/.
1 2  Karlin-Smith. “Trump finalizes rule to require drug prices in TV ads”. Politico. 2019年5月9日閲覧。
1 2 3  “Direct-to-Consumer Pharmaceutical Advertising: Therapeutic or Toxic?”. P & T 36 (10):  669–84. (October 2011). PMC 3278148. PMID 22346300. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278148/.
1 2  “The untold story of TV's first prescription drug ad”. STAT (2015年12月11日). 2019年5月11日閲覧。
1 2 3  “Ten Years Later: Direct to Consumer Drug Advertising”. Ad Age (2006年10月1日). 2019年5月11日閲覧。
↑  “Drug Industry DTC Ad Guidelines Draw Criticism”. Cardiology News (September 1, 2005). 2019年5月12日閲覧。
↑  “PHARMACEUTICAL INDUSTRY ISSUES DTC AD GUIDELINES”. Ad Age (2005年8月2日). 2019年5月12日閲覧。
↑  “Direct-to-consumer advertising under fire”. WHO. 2019年5月11日閲覧。
1 2  “Drug ads: $5.2 billion annually -- and rising”. CBS News. 2019年5月11日閲覧。
↑  “American Medical Association urges ban on TV drug ads”. Washington Post (November 15, 2015). May 11, 2019閲覧。
↑  says (2016年3月4日). “Lawmaker seeks to end tax breaks for consumer drug ads”. STAT. 2019年5月11日閲覧。
↑  Karlin-Smith. “Trump issues rule to require drug prices in TV ads, rejecting industry plan”. Politico. 2019年5月9日閲覧。
↑  Pear, Robert (2018年10月15日). “Trump Rule Would Compel Drug Makers to Disclose Prices in TV Commercials”. The New York Times. ISSN 0362-4331. https://www.nytimes.com/2018/10/15/us/politics/drug-industry-consumer-price-lists.html 2019年5月9日閲覧。
↑  Thrush, Glenn; Thomas, Katie (2019年5月8日). “Drug Prices Will Soon Appear in Many TV Ads”. The New York Times. ISSN 0362-4331. https://www.nytimes.com/2019/05/08/us/politics/drug-prices-tv-advertisements.html 2019年5月9日閲覧。
↑  “Direct-to-consumer marketing of prescription drugs: a current perspective for neurologists and psychiatrists”. CNS Drugs 18 (2):  69–77. (February 1, 2004). doi:10.2165/00023210-200418020-00001. PMID 14728054.
↑  Iizuka, Toshiaki; Jin, Ginger Zhe (September 1, 2005). “The Effect of Prescription Drug Advertising on Doctor Visits”. Journal of Economics & Management Strategy 14 (3):  701–727. doi:10.1111/j.1530-9134.2005.00079.x. ISSN 1530-9134.
1 2  “Effects of patient medication requests on physician prescribing behavior: results of a factorial experiment”. Medical Care 52 (4):  294–9. (April 2014). doi:10.1097/MLR.0000000000000096. PMC 4151257. PMID 24848203. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151257/.
1 2  Metzl, Jonathan. “Selling Sanity Through Gender.” Ms Magazine, Fall, 2003.
↑  “CDC Press Releases”. CDC. https://www.cdc.gov/media/releases/2016/p0503-unnecessary-prescriptions.html August 12, 2017閲覧。
↑  “Cause and Effect: Do Prescription Drug Ads Really Work? - Knowledge@Wharton”. Knowledge@Wharton. http://knowledge.wharton.upenn.edu/article/prescription-drug-ads/ July 28, 2017閲覧。
↑  “Direct marketing of pharmaceuticals to consumers”. Annual Review of Public Health 23 (1):  73–91. (May 1, 2002). doi:10.1146/annurev.publhealth.23.100901.140537. PMID 11910055.
↑  Anderson, Richard (November 6, 2014). “Pharmaceutical industry gets high on fat profits”. BBC News. https://www.bbc.com/news/business-28212223 August 12, 2017閲覧。
↑  Orelli, Brian (June 9, 2017). “6 Reasons Why Prescription Drug Prices Are Extremely Expensive -- The Motley Fool”. The Motley Fool. https://www.fool.com/investing/2017/06/09/7-reasons-why-prescription-drug-prices-are-extreme.aspx August 12, 2017閲覧。
↑  Peter C. Gøtzsche (2013). Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare. Taylor & Francis. p. 275. ISBN 9781846198847
↑  “A decade of direct-to-consumer advertising of prescription drugs”. The New England Journal of Medicine 357 (7):  673–81. (August 2007). doi:10.1056/NEJMsa070502. PMID 17699817.
↑  “Updated: CSL’s Misleading Promo Materials Result in FDA Untitled Letter”. RAPS (March 7, 2018). 2019年12月17日閲覧。
↑  “Pharma watchers on Twitter chat up Johnson & Johnson Xarelto TV ad that seems 'misleading'” (英語). FiercePharma. 2019年11月14日閲覧。
↑  “Sex, gender, and pharmaceutical politics: From drug development to marketing”. Gender Medicine 7 (4):  357–70. (August 2010). doi:10.1016/j.genm.2010.08.003. PMID 20869636.